4//SEC Filing
Schamroth Michael 4
Accession 0001062993-18-003593
CIK 0000875622other
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 5:36 PM ET
Size
6.3 KB
Accession
0001062993-18-003593
Insider Transaction Report
Form 4
Schamroth Michael
Director
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value
2018-08-29$20.00/sh+15,000$300,000→ 99,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-08-29−15,000→ 0 totalExercise: $20.00From: 2009-09-08Exp: 2018-09-07→ Common Stock, $0.001 par value (15,000 underlying)
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeother
Related Parties
1- filerCIK 0001375385
Filing Metadata
- Form type
- 4
- Filed
- Aug 29, 8:00 PM ET
- Accepted
- Aug 30, 5:36 PM ET
- Size
- 6.3 KB